AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29253555 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during endurance test
Number of subjects: 19
Study 29253555 — intervention group
Group type: COMPARATOR
Intervention: No music during endurance test
Number of subjects: 19
Study 27368257 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated self‐management monitor (ASMM)
Number of subjects: 44
Study 27368257 — intervention group
Group type: COMPARATOR
Intervention: Delayed start group (DG)
Number of subjects: 44
Study 24736388 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural trait-focused intervention (n=519)
Number of subjects: 1047
Study 24736388 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (n=528)
Number of subjects: 1047
Study 22327097 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised cognitive behaviour therapy (CCBT)
Number of subjects: 80
Study 22327097 — intervention group
Group type: COMPARATOR
Intervention: Wait list control (WLC)
Number of subjects: 80
Study 20172900 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioline
Number of subjects: 30
Study 20172900 — intervention group
Group type: EXPERIMENTAL
Intervention: Phisio
Number of subjects: 30
Study 17658985 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Treatment (IT)
Number of subjects: 30
Study 17658985 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WL)
Number of subjects: 30
Study 16108749 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal block with bupivacaine 1 mL/kg after anesthetic induction
Number of subjects: 50
Study 16108749 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac suppository 3 mg/kg postinduction and local anesthetic infiltration at port sites
Number of subjects: 50
Study 12351933 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 202
Study 12351933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 11167952 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg intranasal mometasone furoate (MF) once daily
Number of subjects: 22
Study 11167952 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral montelukast plus 10 mg oral cetirizine once daily (MON/CZ)
Number of subjects: 22
Study 11167952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9552083 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (HRT + etidronate)
Number of subjects: 72
Study 9552083 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT alone
Number of subjects: 72
Study 9552083 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate alone
Number of subjects: 72
Study 9552083 — intervention group
Group type: COMPARATOR
Intervention: Calcium and vitamin D (Control group)
Number of subjects: 72
Study 9552083 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT, etidronate, combined therapy
Number of subjects: 72
Study 9552083 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 72
Study 7817849 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional feminine role (marriage, motherhood, housing)
Number of subjects: 630
Study 7817849 — intervention group
Group type: EXPERIMENTAL
Intervention: Living with husband, children, parents and/or parents‐in‐law
Number of subjects: 630
Study 7817849 — intervention group
Group type: COMPARATOR
Intervention: Occupational status
Number of subjects: 630
Study 7817849 — intervention group
Group type: EXPERIMENTAL
Intervention: General Health Questionnaire 60‐items (GHQ‐60)
Number of subjects: 630
Study 2845694 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 0.5 mg/kg
Number of subjects: 60
Study 2845694 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 0.04 mg/kg
Number of subjects: 60
Study 2845694 — intervention group
Group type: COMPARATOR
Intervention: Control (Atracurium)
Number of subjects: 60
Study 2845694 — intervention group
Group type: COMPARATOR
Intervention: Control (Pancuronium)
Number of subjects: 60
Study 29426304 — intervention group
Group type: EXPERIMENTAL
Intervention: modified directly observed therapy
Number of subjects: 150
Study 29426304 — intervention group
Group type: EXPERIMENTAL
Intervention: group treatment
Number of subjects: 150
Study 29426304 — intervention group
Group type: COMPARATOR
Intervention: self‐administered individual treatment (control)
Number of subjects: 150
Study 28156250 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep rTMS with H-coil
Number of subjects: 18
Study 28156250 — intervention group
Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 18
Study 28156250 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS using figure-8 coil
Number of subjects: 18
Study 25082830 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel nicotine inhaler device (0.45 mg and 0.67 mg)
Number of subjects: 48
Study 25082830 — intervention group
Group type: COMPARATOR
Intervention: Nicorette® Inhalator (10 mg)
Number of subjects: 48
Study 24277401 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean liquid integral protein diet for 3 days before operation without mechanical bowel preparation
Number of subjects: 60
Study 24277401 — intervention group
Group type: COMPARATOR
Intervention: Traditional diet and mechanical bowel preparation
Number of subjects: 60
Study 21515531 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for patients with type 1 diabetes
Number of subjects: 53
Study 21515531 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for patients with type 2 diabetes
Number of subjects: 53
Study 21515531 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for patients with schizophrenia
Number of subjects: 53
Study 21515531 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for patients with epilepsy
Number of subjects: 53
Study 21515531 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for retired patients
Number of subjects: 53
Study 21515531 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for unemployed patients
Number of subjects: 53
Study 17690160 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 plasma concentration in patients with ACS
Number of subjects: 3179
Study 17690160 — intervention group
Group type: COMPARATOR
Intervention: IL-10 plasma concentration in healthy controls
Number of subjects: 3179
Study 17690160 — intervention group
Group type: EXPERIMENTAL
Intervention: 1170 CC genotype
Number of subjects: 3179
Study 16990165 — intervention group
Group type: EXPERIMENTAL
Intervention: Participating families with high socioeconomic status and health-related lifestyle factors (non-smoking parents)
Number of subjects: 198
Study 16990165 — intervention group
Group type: COMPARATOR
Intervention: Non-participating families
Number of subjects: 198
Study 14727937 — intervention group
Group type: EXPERIMENTAL
Intervention: roxifiban (DMP754) 2 mg/day
Number of subjects: 120
Study 14727937 — intervention group
Group type: EXPERIMENTAL
Intervention: roxifiban (DMP754) 2.5 mg/day
Number of subjects: 120
Study 14727937 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120
Study 14727937 — intervention group
Group type: EXPERIMENTAL
Intervention: roxifiban (DMP754) (all dosages)
Number of subjects: 120
Study 11225737 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonabusive spanking used to back up milder disciplinary tactics
Number of subjects: 6
Study 11225737 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanking (frequent use)
Number of subjects: 6
Study 11225737 — intervention group
Group type: COMPARATOR
Intervention: Alternative disciplinary tactics
Number of subjects: 6
Study 8630199 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine (450 mg/day)
Number of subjects: 15
Study 8630199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 1362305 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (Rohypnol tabl. 1 mg), Tramadol (Tramal caps. 50 mg), Metipranolol (Trimepranol tabl. 10 mg)
Number of subjects: 8
Study 1362305 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of drugs with Metipranolol
Number of subjects: 8
Study 31456848 — intervention group
Group type: EXPERIMENTAL
Intervention: Descending light intensities bleaching protocol
Number of subjects: 24
Study 31456848 — intervention group
Group type: COMPARATOR
Intervention: High light intensity bleaching protocol
Number of subjects: 24
Study 29220825 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual nutritional education (Group C)
Number of subjects: 265
Study 29220825 — intervention group
Group type: COMPARATOR
Intervention: Doctor's weight loss advice (Group B)
Number of subjects: 265
Study 29220825 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Group A)
Number of subjects: 265
Study 27116464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20mg/d
Number of subjects: 39
Study 24508669 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-sodium fluoride (18F-NaF)
Number of subjects: 30
Study 24508669 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-fluorodeoxyglucose (18F-FDG)
Number of subjects: 30
Study 24508669 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological characterization of the aortic valve
Number of subjects: 30
Study 22398821 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 μg/kg ephedrine
Number of subjects: 120
Study 22398821 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg lidocaine
Number of subjects: 120
Study 22398821 — intervention group
Group type: COMPARATOR
Intervention: 5 ml NaCl 0.9% (placebo)
Number of subjects: 120
Study 21909028 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg/day)
Number of subjects: 90
Study 21909028 — intervention group
Group type: COMPARATOR
Intervention: T3 (tri-iodothyronine) or matching placebo
Number of subjects: 90
Study 17604880 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended dosing schedule (0, 10, 13, 32 weeks)
Number of subjects: 13
Study 17604880 — intervention group
Group type: COMPARATOR
Intervention: Regular dosing schedule (0, 3, 6, 32 weeks)
Number of subjects: 13
Study 15642075 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 115
Study 15642075 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 115
Study 12398957 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)
Number of subjects: 2211
Study 11775818 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive studies published in the Chinese Journal of Tuberculosis and Respiratory Diseases
Number of subjects: 394
Study 11775818 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of study design
Number of subjects: 394
Study 11775818 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement of research design and statistical methods
Number of subjects: 394
Study 7539821 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual product (tape-slide series) explaining a first dental examination
Number of subjects: 28
Study 7539821 — intervention group
Group type: COMPARATOR
Intervention: Previous study with developmentally disabled children
Number of subjects: 28
Study 1967666 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitozantrone 14 mg/m2 intravenously every 3 weeks for 9 weeks
Number of subjects: 132
Study 1967666 — intervention group
Group type: COMPARATOR
Intervention: Continue chemotherapy
Number of subjects: 132
Study 1967666 — intervention group
Group type: COMPARATOR
Intervention: Stop chemotherapy
Number of subjects: 132
Study 7358147 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxapadol (MD 720111)
Number of subjects: 0
Study 7358147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31437008 — intervention group
Group type: EXPERIMENTAL
Intervention: Management by Alternative Care Providers (ACPs) with same-day sleep physician review
Number of subjects: 156
Study 31437008 — intervention group
Group type: COMPARATOR
Intervention: Sleep physician management
Number of subjects: 156
Study 28756764 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoting Early Presentation intervention
Number of subjects: 867
Study 28756764 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 867
Study 27768678 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 30
Study 27768678 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive plate osteosynthesis (MIPO)
Number of subjects: 30
Study 24332432 — intervention group
Group type: EXPERIMENTAL
Intervention: Sayana Press (SP)
Number of subjects: 357
Study 24332432 — intervention group
Group type: COMPARATOR
Intervention: DMPA-IM
Number of subjects: 357
Study 21988932 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 0
Study 21988932 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 0
Study 18486133 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of an educational programme for nurses combined with a nurse specialist's consultation
Number of subjects: 105
Study 18486133 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 105
Study 17502340 — intervention group
Group type: EXPERIMENTAL
Intervention: UK-338,003 (N-[2-(4-amino-6,7-dimethoxy-5-pyridin-2-yl-quinazolin-2-yl)-1,2,3,4-tetrahydro-isoquinolin-5-yl]-methanesulfonamide)
Number of subjects: 0
Study 15055867 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 0
Study 15055867 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (in patients not receiving ACEIs at baseline)
Number of subjects: 0
Study 15055867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11845946 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene cream 0.1%
Number of subjects: 237
Study 11845946 — intervention group
Group type: COMPARATOR
Intervention: Cream vehicle
Number of subjects: 237
Study 9509440 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril renal scintigraphy
Number of subjects: 28
Study 9509440 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex Doppler sonography
Number of subjects: 28
Study 7511494 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fluid gelatin (group A)
Number of subjects: 28
Study 7511494 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyethyl starch (group B)
Number of subjects: 28
Study 3245823 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic permanent pacing
Number of subjects: 14
Study 3245823 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 14
Study 30187497 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative motivation (unpleasant electric stimulation for detected lies)
Number of subjects: 0
Study 30187497 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no specific motivation)
Number of subjects: 0
Study 28177908 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/d and Ezetimibe 10 mg/d
Number of subjects: 230
Study 28177908 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 20 mg/d
Number of subjects: 230
Study 25541389 — intervention group
Group type: EXPERIMENTAL
Intervention: ACDC-rTMS (double cone coil stimulation of the anterior cingulate cortex)
Number of subjects: 45
Study 25541389 — intervention group
Group type: EXPERIMENTAL
Intervention: butterfly-rTMS (conventional rTMS of the left DLPFC)
Number of subjects: 45
Study 25541389 — intervention group
Group type: COMPARATOR
Intervention: sham-stimulation
Number of subjects: 45
Study 23601793 — intervention group
Group type: EXPERIMENTAL
Intervention: Left DLPFC rTMS stimulation
Number of subjects: 0
Study 23601793 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21398040 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive emotional style (PES)
Number of subjects: 40
Study 21398040 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective measure of positive affect (POMS vigour)
Number of subjects: 40
Study 19730304 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% lidocaine administered through the vacuum-assisted closure tubing into the foam dressing 30 minutes before dressing change
Number of subjects: 70
Study 19730304 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline administered through the vacuum-assisted closure tubing into the foam dressing 30 minutes before dressing change
Number of subjects: 70
Study 19730304 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% lidocaine
Number of subjects: 70
Study 19730304 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 70
Study 17210817 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative measures of medial temporal atrophy (MTA)
Number of subjects: 190
Study 17210817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 17210817 — intervention group
Group type: COMPARATOR
Intervention: Donepezil hydrochloride or vitamin E
Number of subjects: 190
Study 15882383 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 74
Study 15882383 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study 12472837 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea catechin (slow release local delivery system applied once a week for 8 weeks)
Number of subjects: 0
Study 12472837 — intervention group
Group type: COMPARATOR
Intervention: Placebo (scaled groups without mechanical treatment)
Number of subjects: 0
Study 12472837 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea catechin (slow release local delivery system)
Number of subjects: 0
Study 9530791 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐Space Fastrak (Polhemus, Colchester, VT) for measuring spinal position sense
Number of subjects: 20
Study 7868425 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 days of head-down tilt
Number of subjects: 7
Study 2475697 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of anipamil
Number of subjects: 121
Study 2475697 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg of anipamil
Number of subjects: 121
Study 2475697 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg of anipamil
Number of subjects: 121
Study 2475697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 781233 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen (200 mg to 600 mg every six hours)
Number of subjects: 0
Study 781233 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (325 mg to 975 mg every six hours)
Number of subjects: 0
Study 781233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 781233 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen
Number of subjects: 0
Study 781233 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 30724099 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaping without nicotine
Number of subjects: 45
Study 30724099 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaping with nicotine
Number of subjects: 45
Study 28188151 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuturing
Number of subjects: 34
Study 28188151 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 34
Study 26143615 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum-adjuvanted trivalent PPrV (50 μg per antigen)
Number of subjects: 280
Study 26143615 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum-adjuvanted trivalent PPrV (10 μg)
Number of subjects: 280
Study 26143615 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum-adjuvanted trivalent PPrV (25 μg)
Number of subjects: 280
Study 26143615 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum-adjuvanted trivalent PPrV (50 μg)
Number of subjects: 280
Study 26143615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study 23300160 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (TIV) plus 7-valent pneumococcal vaccine (PCV7)
Number of subjects: 0
Study 23300160 — intervention group
Group type: COMPARATOR
Intervention: Trivalent inactivated influenza vaccine (TIV) alone
Number of subjects: 0
Study 23300160 — intervention group
Group type: COMPARATOR
Intervention: 7-valent pneumococcal vaccine (PCV7) alone
Number of subjects: 0
Study 21450933 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-use complementary food (RUCF) paste
Number of subjects: 1400
Study 21450933 — intervention group
Group type: COMPARATOR
Intervention: Standard corn-soy blend (UNIMIX) porridge
Number of subjects: 1400
Study 18164470 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 0
Study 18164470 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential current
Number of subjects: 0
Study 18164470 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation
Number of subjects: 0
Study 18164470 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 0
Study 18164470 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermotherapy
Number of subjects: 0
Study 16872455 — intervention group
Group type: EXPERIMENTAL
Intervention: Endo Twinn heat plus vibration function
Number of subjects: 64
Study 16872455 — intervention group
Group type: COMPARATOR
Intervention: Endo Twinn heat function
Number of subjects: 64
Study 14719424 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 50
Study 14719424 — intervention group
Group type: COMPARATOR
Intervention: 0.5% racemic bupivacaine
Number of subjects: 50
Study 10207205 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 inhalation
Number of subjects: 45
Study 10207205 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath holding
Number of subjects: 45
Study 10207205 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebreathing
Number of subjects: 45
Study 10207205 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary hyperventilation
Number of subjects: 45
Study 7821097 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication of Helicobacter pylori infection; N = 41
Number of subjects: 83
Study 7821097 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent Helicobacter pylori infection; N = 42
Number of subjects: 83